Literature DB >> 15011837

REG I as a marker for human pancreatic acinoductular cells.

Ekmel Tezel1, Tetsuro Nagasaka, Gaye Tezel, Tetsuya Kaneko, Shin Takasawa, Hiroshi Okamoto, Akimasa Nakao.   

Abstract

BACKGROUND/AIMS: Several studies have suggested that pancreatic exocrine cells are able to differentiate into endocrine cells. REG I has been shown to be crucial for induction of ductal epithelial cells to differentiate into insulin producing cells. To date, however, there has been no study which examined the expression of REG I along with other differentiation markers in patients with chronic pancreatitis.
METHODOLOGY: Six cases with chronic pancreatitis and the pancreata from the age-matched autopsy cases of unrelated diseases (n=2) were included in this study and examined by immunostaining methods using antibodies against human REG I protein, trypsin, insulin, chromogranin A, cytokeratin 19 and Ki-67.
RESULTS: In chronic pancreatitis, REG I was found in acinar and acinoductular cells and the latter were also characterized by cytokeratin 19 positivity. The acinoductular cells showed the budding of REG I-positive cells which were also trypsin- and chromogranin A-positive. MIB-1 antibody against Ki-67 was found negative in the ductal, acinoductular and islet cells reflecting low proliferation in these cells.
CONCLUSIONS: The current study revealed that acinoductular cells characterized by dual expression of REG I and cytokeratin 19 also express insulin, chromogranin A and trypsin and therefore supports the hypothesis that transdifferentiation of fully differentiated (acinar) cells may be the main source of islet neogenesis in patients with chronic pancreatitis. However, low proliferation rate in these cells limits the regeneration capacity of the pancreatic tissue in these cases. The present results of double staining of REG I with cytokeratin 19, chromogranin A and insulin in the acinoductular cells indicate that REG I may be used as a marker for these cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15011837

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  11 in total

1.  Remodeling the exocrine pancreas at metamorphosis in Xenopus laevis.

Authors:  Sandeep Mukhi; Jinzhe Mao; Donald D Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-23       Impact factor: 11.205

2.  Transdifferentiation of tadpole pancreatic acinar cells to duct cells mediated by Notch and stromelysin-3.

Authors:  Sandeep Mukhi; Donald D Brown
Journal:  Dev Biol       Date:  2010-12-29       Impact factor: 3.582

3.  Persistent hyperinsulinemic hypoglycemia of infancy: constitutive activation of the mTOR pathway with associated exocrine-islet transdifferentiation and therapeutic implications.

Authors:  Sanda Alexandrescu; Nina Tatevian; Oluyinka Olutoye; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2010-08-08

4.  Feeder-cell-independent culture of the pig embryonic stem cell-derived exocrine pancreatic cell line, PICM-31.

Authors:  Neil C Talbot; Amy E Shannon; Caitlin E Phillips; Wesley M Garrett
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-02-13       Impact factor: 2.416

5.  Activation of the Reg family genes by pancreatic-specific IGF-I gene deficiency and after streptozotocin-induced diabetes in mouse pancreas.

Authors:  Yarong Lu; André Ponton; Hiroshi Okamoto; Shin Takasawa; Pedro L Herrera; Jun-Li Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-01-31       Impact factor: 4.310

6.  Pancreatic regenerating protein I in chronic pancreatitis and aging: implications for new therapeutic approaches to diabetes.

Authors:  Martin Bluth; Cathy M Mueller; Joelle Pierre; Gordon Callender; Emad Kandil; Domenico Viterbo; Sophia L Fu; Akira Sugawara; Hiroshi Okamoto; Michael E Zenilman
Journal:  Pancreas       Date:  2008-11       Impact factor: 3.327

7.  Prospective markers for early diagnosis and prognosis of sporadic pancreatic ductal adenocarcinoma.

Authors:  Martin Tobi; Mijin Kim; Douglas H Weinstein; Mary Ann Rambus; James Hatfield; N Volkan Adsay; Edi Levi; Douglas Evans; Michael J Lawson; Suzanne Fligiel
Journal:  Dig Dis Sci       Date:  2012-09-22       Impact factor: 3.199

8.  Administration of anti-Reg I and anti-PAPII antibodies worsens pancreatitis.

Authors:  Domenico Viterbo; Gordon E Callender; Theresa DiMaio; Cathy M Mueller; Tamar Smith-Norowitz; Michael E Zenilman; Martin H Bluth
Journal:  JOP       Date:  2009-01-08

9.  Regenerating proteins and their expression, regulation and signaling.

Authors:  Abhirath Parikh; Anne-Fleur Stephan; Emmanuel S Tzanakakis
Journal:  Biomol Concepts       Date:  2011-11-10

Review 10.  Xenopus pancreas development.

Authors:  Esther J Pearl; Cassandra K Bilogan; Sandeep Mukhi; Donald D Brown; Marko E Horb
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.